This is the seventh special EBMT report on the indications for haematopoietic stem cell
transplantation for haematological diseases, solid tumours and immune disorders. Our aim …

This is the sixth special report that the European Society for Blood and Marrow
Transplantation regularly publishes on the current practice and indications for …

Allogeneic transplantation of hematopoietic cells is an effective treatment of leukemia, even
in advanced stages. Allogeneic lymphocytes produce a strong graft-versus-leukemia (GVL) …

Infections are the most common and significant cause of mortality and morbidity after
allogeneic hematopoietic stem cell transplantation (allo-HSCT). The presence of …

Allogeneic hematopoietic stem cell transplantation (HSCT) has advanced to a common
procedure for treating also older patients with malignancies and immunodeficiency …

Clinical laboratory analyses aid in the diagnosis and management of human allergic (IgE-
dependent) diseases. Diagnosis of immediate-type hypersensitivity begins with a thorough …

There are many types of stem cells. All share the characteristics of being able to self-renew
and to give rise to differentiated progeny. Over the last decades, great excitement has been …

Tumors originate from a number of genetic events that deregulate homeostatic mechanisms
controlling normal cell behavior. The immune system, devoted to patrol the organism against …

Allogeneic haematological stem cell transplantation (HSCT) has developed into
immunotherapy. Donor CD4+, CD8+ and natural killer (NK) cells have been reported to …

Our understanding of cancer biology has been radically transformed over recent years with
a more realistic grasp of its multilayered cellular and genetic complexity. These advances …